Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-18

Clinical Trial Update: DMT210 Topical Gel in the Treatment of Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of DMT210 topical gel for atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DMT210 (DMT210)

Snippet

Sponsor: Dermata Therapeutics | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED